Co-funding Institute(s):
National Institute on Aging (NIA)
Drug Discovery for Neurodegeneration
February 2, 2009 - February 3, 2009
Washington, DC, United States
Contact for additional information: Dr. Suzana Petanceska, NIA 301-594-7754
DescriptionThe objectives of this Alzheimer's Drug Discovery Foundation (ADDF) conference are to: 1. Train a cadre of interdisciplinary scientists in the principles of drug discovery for neurodegenerative disease. 2. Provide a platform for scientists to exchange ideas, knowledge and resources about drug discovery for neurodegenerative disease. 3. Stimulate pre-clinical research in the discovery and testing of novel compounds aimed at the prevention and treatment of neurodegenerative disease. 4. Build public-private partnerships that will accelerate drug discovery for neurodegenerative disease. 5. Publish the conference proceedings in a scientific journal available on PubMed. 6. Provide Continuing Medical Education (CME) credits.
Additional Information: Conference Web Site